Plus Therapeutics, Inc. Alternatives & Competitors
12 companies similar to Plus Therapeutics, Inc. — Power and precision in cancer radiotherapeutics.
Companies similar to Plus Therapeutics, Inc.
MimiVax, Inc.
Disrupting Cancer with Immunotherapy
Buffalo, United States
Cornerstone Pharmaceuticals
Rare Science. Rare Compassion. Rare Solutions.
Cranbury, United States
Rexahn Pharmaceuticals
TARGETING DIFFICULT TO TREAT CANCERS
Rockville, United States
Ayala Pharmaceuticals
Clinical-stage oncology company focused on developing and commercializing small molecule t...
Wilmington, United States
Track all Plus Therapeutics, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Inspirna, Inc.
Converting cancer to a manageable, chronic condition
New York, United States
Moleculin Biotech, Inc.
Groundbreaking Cancer Therapies
Houston, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Telix Pharmaceuticals Limited
See it. Treat it.
Australia
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
South San Francisco, Unit...
Cavion
Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...
Sopherion Therapeutics
Innovating metastatic breast cancer treatment through advanced nanotechnology solutions.
About Plus Therapeutics, Inc.
Plus Therapeutics, Inc., known for its slogan "Power and precision in cancer radiotherapeutics," stands as a noteworthy player in the pharmaceutical industry. Founded in 2019, this U.S.-based clinical-stage company is focused on developing cutting-edge radiotherapeutics targeted at rare and challenging cancer types aff...
Development of targeted radiotherapeutics, Clinical trials for cancer therapies, Research on drug delivery systems for cancer treatment, Diagnostics for CNS cancer
Patients with rare and difficult-to-treat cancers, Healthcare providers specializing in oncology, Pharmaceutical companies looking for partnerships, Investors in biopharma
Clinical-stage Pharmaceuticals, Radiotherapeutics, Targeted Therapy, Rare Cancers, Glioblastoma, Leptomeningeal Metastases, Pediatric Brain Cancer, Nanotechnology, Oncology, Radiopharmaceuticals, Innovative Drug Development, Nanomedicine, Drug Delivery, Clinical Trials, Liposome Technology
B2B, B2B2C
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Plus Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Plus Therapeutics, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
